Stock STEK STEMTECH CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Company Stemtech Corporation

Equities

STEK

US85859W1027

Pharmaceuticals

Delayed OTC Markets
Other stock markets
 16:21:07 03/07/2024 BST 		5-day change 1st Jan Change
0.0611 USD +14.57% Intraday chart for Stemtech Corporation +5.89% +88.00%
01-31 Stemtech Corporation Expands Global Reach with New License Agreement in Africa CI
2023 Stemtech Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Business Summary

Stemtech Corporation is a global network marketing company that develops science-based products, which support wellness by helping the body maintain healthy stem cell physiology, also known as stem cell enhancers. The Company is also known as Stem Cell Nutrition Company. The Company's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood and migrate them into tissues, where they can perform their daily function of renewal for optimal health. These products are marketed internationally by the Companies subsidiaries and through independent distributors. The Company markets its products under various brands, which include RCM System, stemrelease3, Stemflo MigraStem, OraStem (Oral Health Care), and D-Fuze (Electromagnetic Frequency blocker). It also introduced a skincare product, Cellect One Rapid Renew Stem Cell Peptide Night Cream. Its segments include North America, Latin America and Asia.

Sales per Business

USD in Million2021Weight2022Weight Delta
Stem Cell Enhancers
100.0 %
4 100.0 % 5 100.0 % +5.51%

Sales per region

USD in Million2021Weight2022Weight Delta
Latin America
54.9 %
2 38.6 % 3 54.9 % +49.94%
Americas
33.9 %
2 43.2 % 2 33.9 % -17.10%
Asia
11.2 %
1 18.2 % 1 11.2 % -35.07%

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 104,476,731 65,342,632 ( 62.54 %) 0 62.54 %

Shareholders

NameEquities%Valuation
Charles Arnold
14.81 %
15,474,926 14.81 % 758 271 $
Javad Abbasi
6.259 %
6,538,748 6.259 % 320 399 $
Leonite Capital LLC
5.543 %
5,791,082 5.543 % 283 763 $
Darryl V. Green
3.794 %
3,963,930 3.794 % 194 233 $
Daniel Kaplan
3.714 %
3,880,578 3.714 % 190 148 $
Benjamin Kaplan
3.521 %
3,678,680 3.521 % 180 255 $
Robert Grinberg
3.254 %
3,400,037 3.254 % 166 602 $
MCUS LLC
2.932 %
3,063,336 2.932 % 150 103 $
Mindshare Holdings, Inc.
2.329 %
2,433,399 2.329 % 119 237 $
John Thatch
1.641 %
1,714,173 1.641 % 83 994 $

Company contact information

Stemtech Corp.

10370 USA Today Way

33025, Miramar

+

http://www.stemtech.com
address Stemtech Corporation(STEK)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per region

Sector Biopharmaceuticals

1st Jan change Capi.
STEMTECH CORPORATION Stock Stemtech Corporation
+88.00% 7.13M
CSL LIMITED Stock CSL Limited
+3.79% 95.71B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+6.58% 41.64B
BIOGEN INC. Stock Biogen Inc.
-13.20% 32.7B
UCB Stock UCB
+79.66% 28.65B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-16.02% 15.38B
INCYTE CORPORATION Stock Incyte Corporation
-8.17% 12.97B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-12.49% 11.47B
ALTEOGEN INC. Stock ALTEOGEN Inc.
+162.44% 9.92B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-54.92% 9.07B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. STEK Stock
  4. Company Stemtech Corporation